Contact Us

Have questions? 

Please email us at casl@hepatology.ca or call us at 780-436-0983 ext.234

         

123 Street Avenue, City Town, 99999

(123) 555-6789

email@address.com

 

You can set your address, phone number, email and site description in the settings tab.
Link to read me page with more information.

2019 Program

2019 PROGRAM

The 2019 Canadian Liver Meeting offers participants with a forum for presentation and discussion of basic science, translational and clinical aspects of liver disease. This is the 2nd year that delegates will receive the opportunity to exchange ideas, promote collaboration and foster knowledge translation among Canadian researchers, healthcare practitioners and community-based groups with interest in Hepatology. 

The program features Canadian and international speakers, the latest research presentations, state of the art symposia, and a wealth of networking opportunities with peers, trainees, allied health practitioners, and industry.

Please note: the session titles and objectives are subject to change.


Saturday, May 25

7:00 AM - 4:00 Pm

Registration Open

7:00 - 7:45 Am

Breakfast Symposia

 

Palliative Care in Patients with End-Stage Liver Disease/Cases
Cynthia Tsien, University of Ottawa

Difficult Cases in Treating Patients with Hepatitis C
Matthew Sadler, Foothills Medical Center &
Curtis Cooper, University of Ottawa

8:00 - 9:15 AM

Concurrent Session

 

Public Heath: HCV Different Models of Care

  • 4-5 different rapid-fire presentations

HCC Basic/Translational: Molecular Mechanisms of HCC in Viral and Non-Viral Hepatitis

  • Molecular mechanism of HCC in Viral Hepatitis
    Ralf Bartenshclager, Heidelberg University

  • Metabolic Profiling of HCC: In Vitro & In Vivo Models of HCC
    Marc Bilodeau, University of Montreal

  • The Role of the Inflammasome in Gastrointestinal Cancers and liver metastasis
    Maya Saleh, McGill University

  • New Medical Therapies for HCC
    Hélène Castel, University of Montreal

9:15 - 9:20 AM

Room Change

9:20 - 10:15 AM

Concurrent Session

 

CAHN Sessions

  • Welcome
    Donna Zukowski, CAHN President
    Session Moderator: Mary Guyton

  • Nutrition in Liver Disease: Practical Counseling Tips
    Chantal Bemeur, University of Montreal

  • Hepatic Encephalopathy: Nursing Interventions
    Elizabeth Lee, University Health Network

Viral Hepatitis Oral Abstract Presentations

  • Incidence and predictors of flares after stopping nucleos(t)ide analogue therapy in HBeAg negative patients with chronic hepatitis B: Results from the randomized controlled STOP Study
    Seng Liem, Toronto Centre for Liver Disease

  • Global real world evidence of sofosbuvir/velpatasvir as a simple, effective regimen for the treatment of chronic hepatitis C patients: Integrated Analysis of 12 clinical practice cohorts
    Alnoor Ramji, University of British Columbia

  • Results of a Birth Cohort Hepatitis C Screening Program in an Academic Emergency Department in Canada
    Camelia Capraru, Toronto Centre for Liver Disease/VIRCAN, UHN

  • Noninvasive prediction of esophageal varices by liver stiffness measurement and platelet count in 590 HIV-infected cirrhotic patients with and without HCV coinfection: multicenter validation of Baveno VI criteria
    Giada Sebastiani, McGill University

  • Prenatal HBsAg screening rates and follow-up DNA testing low in Ontario
    Mia Biondi, Toronto General Hospital, UHN

10:15 - 10:45 AM

Break, Poster, & Exhibit Viewing

10:45 - 12:30 PM

Concurrent Session

 

Mechanisms of Liver Injury & Repair in NAFLD & Viral Hepatitis

  • Immunopathogenesis of Hepatitis B
    Adam Gehring, University Health Network

  • Analysis of Virus Induced Mechanisms of Programmed Cell Death
    Rodney Russell, Memorial University

  • The Liver as Frontline Immune Organ
    Craig Jenne, University of Calgary

  • Insulin Signaling in NAFLD & NAFLD-related HCC
    Jennifer Estall, McGill University

New Clinical Developments

  • NAFLD
    Saumya Jayakumar, University of Calgary

  • Alcohol

  • Viral Hepatitis
    Mark Sulkowski, Johns Hopkins Medicine

  • The Challenge of Fontan Associated Liver Disease

12:30 - 1:30 PM

Lunch, Poster & Exhibit Viewing

1:30 - 3:00 Pm

Concurrent Session

 

Evolving Evidence in Liver Disease Pathogenesis and Best Clinical Management

  • Novel Mechanisms Linking Blood Coagulation to Liver Injury and Regeneration
    Jim Luyendyke, Michigan State University

  • Overview of Hepatitis B Reactivation: Current Concepts, Molecular Mechanisms and Management
    Norah Terrault, University of California San Francisco

  • Translational Research in Alcoholic Hepatitis from iTeam (NIH Consortium)

  • HCV Treatment in HCC: Yes or No? A Debate
    Kelly Burak, University of Calgary

Public Health and Best Practice Clinical Management

  • Nutrition Updates in NAFLD and Cirrhosis
    Maitreyi Raman, University of Calgary

  • Public Health Approaches In Childhood Obesity
    Shazhan Amed, University of British Columbia

  • Up-to-Date Diagnosis & Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension
    Samir Gupta, University of Toronto

3:00 - 3:30 PM

Break, Poster & Exhibit Viewing

3:30 - 5:00 PM

CASL-CLF Sass-Kortsak Lecture & Pediatric Symposium

CASL-CLF Sass-Kortsak Lecture
Fernando Alvarez, University of Montreal

Biliary Atresia in Long-Term Kasai Survivors
Richard Schreiber, University of British Columbia

Autoimmune Hepatitis & PSC
Orlee Guttman, University of British Columbia
Aldo Montano-Loza, University of Alberta

Congenital Hepatic Fibrosis in the Long-Term Outcome of Autosomal recessive Polycystic Kidney Disease
Steve Martin, University of Calgary

 

3:30 - 5:00 PM

CAHN Sessions

HCV Models of Care Among Priority Populations: Nursing Practice and Pearls

  • Prison System
    Dennaye Fuchs, Saskatchewan Health Authority

  • Supervised Injection/Overdose Prevention
    Bernadette Lettner & Kate Mason, South Riverdale Community Health Centre

  • Northern Indigenous Communities

  • Homeless
    Jacqueline Atkinson, Mobile Outreach Street Health

  • Newcomer HCV Linkage

    Moderator: Mia Biondi, Toronto General Hospital, UHN

The Next Liver Disease of Focus: Alcohol or NASH?
David Wong, University Health network
Ed Tam, Lair Centre

Moderator: Colina Yim, University Health Network

5:00 Pm

CASL Annual General Meeting (CASL Members Only)